Le Lézard
Classified in: Science and technology
Subject: PER

eClinical Solutions Expands Leadership Team, elluminate & Enhanced Clinical Data Strategy Services


MANSFIELD, Mass., Jan. 16, 2020 /PRNewswire-PRWeb/ -- eClinical Solutions LLC, a leading global provider of cloud-based enterprise software and software-driven clinical data services, today announced the appointment of Robert Musterer as the company's Vice President of Product Management as part of its expansion due to increased demand for the elluminate®? Clinical Data Hub and technology enabled services. The increase in data sources and the accelerated pace of innovation in the life sciences industry have made formal data strategies, a centralized data hub, data management workbenches and improved analytics more vital than ever in bringing new therapies to market faster. These issues continue to be pressing concerns for life sciences companies. As noted in a recent report by Gartner, Life Science CIOs: Embrace Next-Generation Data and Analytics Platforms to Manage Clinical Data Challenges*, "according to Gartner's 2019 CIO Survey, 46% of life science CIOs state that BI/data analytics capabilities will receive the largest amount of new or additional investments."

Highlighted in the Gartner report as an example vendor of an analytics workbench, eClinical Solutions and its powerful elluminate®? platform are driving improved insight and control over clinical data. The addition of Rob Musterer, a clinical systems expert with over 25 years of experience in clinical programming, biostatistics and data management in large pharmaceutical companies including Bayer Healthcare and Schering-Plough Pharmaceuticals, helps to strengthen the customer and end-user knowledge of the eCS product strategy function.

"We are delighted to welcome Rob to the eClinical Solutions leadership team," said Raj Indupuri, CEO of eCS. "His in-depth knowledge and experience in clinical research as a client and end-user of platforms like elluminate will help to accelerate the execution of the elluminate product roadmap."

Rob most recently served as the President of ER Squared, a consultancy helping life sciences companies of all sizes to establish successful data strategies and to identify the best fit technology infrastructure and implementation processes. "I worked with numerous clients across the industry and consistently heard about their challenges managing and accessing more sources and types of external data and finding better ways to conduct automated and comprehensive data review. I joined eCS as the elluminate platform meets these needs and more. It also presents a unique opportunity to automate currently manual processes like data mapping and data review with AI/ML capabilities resulting in dramatic time, cost, and quality improvements in clinical development."

Additionally, eCS has doubled their Boston-area headquarters with almost 12,000 square feet of new office space. In the last three years, the company has grown significantly year-over-year and expects to aggressively hire new team members in the U.S. in 2020. eClinical Solutions also recently expanded into the European market adding new team members in the U.K.

*Gartner, Life Science CIOs: Embrace Next-Generation Data and Analytics Platforms to Manage Clinical Data Challenges, Jeff Smith, 22 October 2019

About eClinical Solutions LLC
eClinical Solutions is a leading global provider of cloud-based enterprise software and software-driven clinical data services. The elluminate platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies. For more information, visit http://www.eclinicalsol.com.

 

SOURCE eClinical Solutions


These press releases may also interest you

at 00:30
Frost & Sullivan recently researched the data center colocation services industry and, based on its findings, recognizes STT GDC India with the 2023 Indian Company of the Year Award. STT GDC India is a pioneer data center solutions provider that...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

at 00:24
In the news release, Roborock Reports 2023 Full Year Financial Results, issued 28-Mar-2024 by Roborock over PR Newswire, we are advised by the company that in the first bullet point of "Growth across Product Categories", the USD amount should read...

28 mar 2024
The opening ceremony of the Boao Forum for Asia (BFA) Annual Conference 2024 was held in Boao, south China's Hainan Province on Thursday, with China's top legislator Zhao Leji stressing China's economic potential, appealing to international investors...

28 mar 2024
OKX Ventures, the investment arm of leading Web3 technology company OKX, has issued updates for March 29, 2024. OKX Ventures...

28 mar 2024
Curio Legacy Ventures (Curio), a frontrunner in nuclear technology innovation, proudly announces a strategic partnership with Navarro Research and Engineering, Inc. (Navarro). This collaboration signals a significant step forward in advancing nuclear...



News published on and distributed by: